[Solid Pediatric Tumors : A Brief Survey of the Rarity Cabinet]

Overview

Journal Pathologe

Specialty Pathology

Date 2017 Jun 24

PMID 28643124

Authors

B Gurtl-Lackner

D Gisselsson-Nord

G Vujanic

Affiliations

Soon will be listed here.

Abstract

Solid tumors in childhood are extremely rare entities, which are usually treated in specialized centers. Diagnosis and therapy are carried out according to a joint European protocol, whereby the pathological evaluation and therapy are carried out according to international guidelines. For the correct diagnosis and/or therapy of most tumors, analysis of specific genetic changes is mandatory; therefore, tumors have to be adequately sampled for parallel genetic analysis during the pathological work-up. A second opinion reference of the histopathological assessment is part of the international guidelines. Neuroblastomas, congenital mesoblastic nephromas and rhabdoid tumors are examples of solid tumors in childhood that are not restricted to one organ and occur exclusively during childhood.

References

Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S . International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer. 2001; 92(9):2451-61. DOI: 10.1002/1097-0142(20011101)92:9<2451::aid-cncr1595>3.0.co;2-s. View

Versteege I, Sevenet N, Lange J, Rousseau-Merck M, Ambros P, Handgretinger R . Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998; 394(6689):203-6. DOI: 10.1038/28212. View

Spitz R, Hero B, Skowron M, Ernestus K, Berthold F . MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification. Eur J Cancer. 2004; 40(18):2753-9. DOI: 10.1016/j.ejca.2004.05.002. View

Shimada H, Ambros I, Dehner L, Hata J, JOSHI V, Roald B . Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer. 1999; 86(2):349-63. View

Peuchmaur M, DAmore E, Joshi V, Hata J, Roald B, Dehner L . Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer. 2003; 98(10):2274-81. DOI: 10.1002/cncr.11773. View

GONZALEZ-CRUSSI F, deMello D, Vogler C, Gooch 3rd W, Gale G, Pena R . Renal and extrarenal rhabdoid tumors in children: a clinicopathologic study of 14 patients. Semin Diagn Pathol. 1986; 3(2):151-63. View

Rubin B, Chen C, Morgan T, Xiao S, Grier H, Kozakewich H . Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998; 153(5):1451-8. PMC: 1853403. DOI: 10.1016/S0002-9440(10)65732-X. View

Weeks D, Beckwith J, Mierau G, Luckey D . Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1989; 13(6):439-58. View

Argani P, Fritsch M, Kadkol S, Schuster A, Beckwith J, Perlman E . Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol. 2000; 13(1):29-36. DOI: 10.1038/modpathol.3880006. View

10.

Argani P, Ladanyi M . Recent advances in pediatric renal neoplasia. Adv Anat Pathol. 2003; 10(5):243-60. DOI: 10.1097/00125480-200309000-00001. View

11.

Gooskens S, Houwing M, Vujanic G, Dome J, Diertens T, Coulomb-LHermine A . Congenital mesoblastic nephroma 50 years after its recognition: A narrative review. Pediatr Blood Cancer. 2017; 64(7). DOI: 10.1002/pbc.26437. View

12.

Gururangan S, Bowman L, Parham D, Wilimas J, Rao B, Pratt C . Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Cancer. 1993; 71(8):2653-9. DOI: 10.1002/1097-0142(19930415)71:8<2653::aid-cncr2820710834>3.0.co;2-#. View

13.

Huang M, Weiss W . Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013; 3(10):a014415. PMC: 3784814. DOI: 10.1101/cshperspect.a014415. View

14.

Agaimy A . The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity. Adv Anat Pathol. 2014; 21(6):394-410. DOI: 10.1097/PAP.0000000000000038. View

15.

Vujanic G, Delemarre J, Moeslichan S, Lam J, Harms D, Sandstedt B . Mesoblastic nephroma metastatic to the lungs and heart--another face of this peculiar lesion: case report and review of the literature. Pediatr Pathol. 1993; 13(2):143-53. DOI: 10.3109/15513819309048202. View

16.

Knezevich S, Garnett M, Pysher T, Beckwith J, Grundy P, Sorensen P . ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998; 58(22):5046-8. View

17.

Maris J, Hogarty M, Bagatell R, Cohn S . Neuroblastoma. Lancet. 2007; 369(9579):2106-20. DOI: 10.1016/S0140-6736(07)60983-0. View

18.

Schneppenheim R, Fruhwald M, Gesk S, Hasselblatt M, Jeibmann A, Kordes U . Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet. 2010; 86(2):279-84. PMC: 2820190. DOI: 10.1016/j.ajhg.2010.01.013. View

19.

England R, Haider N, Vujanic G, Kelsey A, Stiller C, Pritchard-Jones K . Mesoblastic nephroma: a report of the United Kingdom Children's Cancer and Leukaemia Group (CCLG). Pediatr Blood Cancer. 2011; 56(5):744-8. DOI: 10.1002/pbc.22871. View

20.

Nakazawa A, Haga C, Ohira M, Okita H, Kamijo T, Nakagawara A . Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma. Cancer Sci. 2015; 106(6):766-771. PMC: 4471784. DOI: 10.1111/cas.12665. View